AKT1 and non-small cell lung carcinoma: found that STXBP5-AS1, an antioncogene, suppressed the expression of STXBP5 in non-small cell lung cancer (NSCLC) by blocking PI3K/AKT, thereby inhibiting the progression of NSCLC.